A brief history of barriers and the current state of diversity in clinical trials
Inclusive Design: Are your trials reflective of the patient population they aim to serve?
How can trials be more reflective of populations with disease?
How can we increase education and awareness to avoid patient bias and improve recruitment?
What are some other approaches to overcome barriers and extend the reach of trials to more diverse participants?
We use cookies and similar technologies to recognize your visits and preferences, as well as to measure the effectiveness of campaigns and analyze traffic. To learn more about cookies, including how to disable them, view our Cookie Policy
Unsupported Browser Detected
The browser you are using is not supported that will prevent you from accessing certain features of the website. We want you to have the best possible experience. For this you'll need to use a supported browser and upgrade to the latest version.